These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 24731221)
1. Role of Fbxw7 expression in hepatocellular carcinoma and adjacent non-tumor liver tissue. Imura S; Tovuu LO; Utsunomiya T; Morine Y; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Yamada S; Ishikawa D; Bando Y; Shimada M J Gastroenterol Hepatol; 2014 Oct; 29(10):1822-9. PubMed ID: 24731221 [TBL] [Abstract][Full Text] [Related]
2. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509 [TBL] [Abstract][Full Text] [Related]
3. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway. Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618 [TBL] [Abstract][Full Text] [Related]
4. [Expression of Fbxw7 and its correlation with cell proliferation in human hepatocellular carcinoma]. Zhou ZY; Tu KS; Zhang J; Zheng X; Gao J; Yao YM; Liu QG Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1303-6. PubMed ID: 23232523 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7. Yang W; Dou C; Wang Y; Jia Y; Li C; Zheng X; Tu K Oncol Rep; 2015 Nov; 34(5):2576-84. PubMed ID: 26323375 [TBL] [Abstract][Full Text] [Related]
6. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E. Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897 [TBL] [Abstract][Full Text] [Related]
7. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma. Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686 [TBL] [Abstract][Full Text] [Related]
8. Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma. Wu WJ; Shi J; Hu G; Yu X; Lu H; Yang ML; Liu B; Wu ZX Tumour Biol; 2016 May; 37(5):6045-51. PubMed ID: 26602384 [TBL] [Abstract][Full Text] [Related]
9. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study. Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128 [TBL] [Abstract][Full Text] [Related]
11. Loss of Fbxw7 expression is a predictor of recurrence in colorectal liver metastasis. Kawashita Y; Morine Y; Ikemoto T; Saito Y; Iwahashi S; Yamada S; Higashijima J; Imura S; Ogawa H; Yagi T; Shimada M J Hepatobiliary Pancreat Sci; 2017 Oct; 24(10):576-583. PubMed ID: 28846828 [TBL] [Abstract][Full Text] [Related]
12. The FBXW7 beta-form is suppressed in human glioma cells. Gu Z; Inomata K; Ishizawa K; Horii A Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947 [TBL] [Abstract][Full Text] [Related]
13. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma. Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021 [TBL] [Abstract][Full Text] [Related]
14. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1). Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332 [TBL] [Abstract][Full Text] [Related]
15. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001 [TBL] [Abstract][Full Text] [Related]
16. FBXW7 overexpression suppresses renal cancer cell proliferation and induces apoptosis. Fu Y; Lin Y; Yang Z; Yang G; Li G; Liu Y; Tan X; Huang Y; Wu X; Wang Y; Xiong H; Zhang M; Fang L; Ge Y; Zeng J; Cai Y; Bai J; Wu S Med Oncol; 2015 Aug; 32(8):215. PubMed ID: 26163148 [TBL] [Abstract][Full Text] [Related]
17. High STAT4 expression is a better prognostic indicator in patients with hepatocellular carcinoma after hepatectomy. Wubetu GY; Utsunomiya T; Ishikawa D; Yamada S; Ikemoto T; Morine Y; Iwahashi S; Saito Y; Arakawa Y; Imura S; Kanamoto M; Zhu C; Bando Y; Shimada M Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S721-8. PubMed ID: 24965572 [TBL] [Abstract][Full Text] [Related]
18. Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance. Iwatsuki M; Mimori K; Ishii H; Yokobori T; Takatsuno Y; Sato T; Toh H; Onoyama I; Nakayama KI; Baba H; Mori M Int J Cancer; 2010 Apr; 126(8):1828-1837. PubMed ID: 19739118 [TBL] [Abstract][Full Text] [Related]
19. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy. Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861 [TBL] [Abstract][Full Text] [Related]
20. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma. Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]